Report Keywords- Single-UseBioreactors, Bioreactor, Roots Analysis, Biotech, Analysis
Roots Analysis has announced the addition of “Single-UseBioreactors Market, 2021-2030” report to its list of offerings.
Traditionally, stainless steelbioreactors were the preferred choice for production of biologics; however,over the past couple of decades, biopharmaceutical manufacturing has gradually witnesseda shift towards the use of single-use technologies. Apart from lowcontamination risk and better product yield, single-use bioreactors areeasy-to-install and have a much smaller footprint, compared to the traditionalstainless steel systems.
To order this 267 page report, which features 110figures and 160 tables, please visit the –
https://www.rootsanalysis.com/reports/single-use-bioreactors-market/request-sample.html
Key Market Insights
160single-use bioreactors are currently available / under development fordifferent scales of operation
It is worth noting that most of the single-use bioreactors (49%) arestirred tank bioreactors, followed by pneumatically mixed bioreactors (9%). It is worth highlighting that nearly 70% of single-use bioreactorssupport laboratory scale operations.
Majority(40%) of the single-use bioreactors are intended for mammalian cell culture
Presently, several bioreactors are also being used to cultureappropriate host cells for studying the pathogenesis of the novel coronavirus. Otherpopular application areas for single-use bioreactors include stem cell research(47%), and cancer research (20%).
Closeto 40 players are driving the activity within the single-use bioreactors industry
Majority (47%) of theinitiatives in this domain are led by small-sized firms, followed by mid-sized(24%) and large players (29%). Further, around 60% ofthe firms engaged in providing single-use bioreactors were established post2000.
Partnership activity in this field has grown at a CAGR of~16%, between 2015 and 2020
Nearly 45% of the reported deals were established after2015, with the maximum activity being reported in 2017. Majority of thepartnerships inked within this domain were product / technology integrationagreements (30%), followed by full business acquisitions (22%) and product /technology development agreements (15%).
2,800+ patents that have been filed / granted forsingle-use bioreactors, till 2020
Based on the intellectual property distributionacross the world, R&D activity related to single-use bioreactors is largelyconcentrated in the US (around 47%). Majority of the patents in this field werefiled by industry players (94%).
NorthAmerica and Europe are anticipated to capture over 33.5% of the market share by2030
Themarket in Asia-Pacific are anticipated to grow at a relatively faster rate(over 20%). In 2030, mammalian cell cultures are likely to capture the largest marketshare (36%) in terms of revenues from product sales, followed by viral cellcultures (20%), microbial cell cultures (15%) and insect cell cultures (11%).
Key Questions Answered
§ Who are the leadingmanufacturers engaged in the development of single-use bioreactors?
§ What are thedifferent applications of single-use bioreactors?
§ Which partnership modelsare commonly adopted by stakeholders in this industry?
§ Which features ofsingle-use bioreactors are most important to end-users?
§ What are thechallenges currently faced by stakeholders in this industry?
§ What are the keyfactors that are likely to influence the evolution of this market?
§ How has the COVID-19pandemic impacted the single-use bioreactors market?
§ How is the currentand future opportunity likely to be distributed across key market segments?
§ What are theanticipated future trends related to single-use bioreactors?
The USD 6.6 billion (by 2030) financial opportunity withinthe single-use bioreactors market has been analyzed across the followingsegments:
§ Type of Cell Culture
§ Bacterial CellCultures
§ Insect Cell Cultures
§ Mammalian CellCultures
§ Microbial CellCultures
§ Plant Cell Cultures
§ Viral Cell Cultures
§ Other Cell Cultures
§ Type of Molecule
§ Cell Therapies
§ Gene Therapies
§ Monoclonal Antibodies
§ Recombinant Proteins
§ Stem Cell Therapies
§ Vaccines
§ Other Molecules
§ Application Area
§ Cancer Research
§ Drug Discovery andToxicity Testing
§ Regenerative Medicineand Tissue Engineering
§ Stem Cell Research
§ Other ApplicationAreas
§ Scale of Operation
§ Small ScaleOperations
§ Large ScaleOperations
§ Purpose
§ Research and Development
§ BiopharmaceuticalManufacturing
§ End-User
§ Biopharmaceutical /Pharmaceutical Industries
§ Academic / ResearchInstitutes
§ Key GeographicalRegions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America (LATM)
§ Middle East and NorthAfrica (MENA)
§ Rest of the World(RoW)
The report featuresinputs from eminent industry stakeholders, according to whom, the US is likelyto dominate this market, despite the fact that the country is currently facingseveral political challenges, as well as problems related to the COVID-19pandemic. The report includes detailed transcripts of discussions held with thefollowing industry experts:
§ Per Stobbe (Chief Executive Officer, Marketing, Technical Support,CerCell)
§ Torsten Due Bryld (Chief Commercial Officer, CelVivo)
The research includes detailed profiles of key players (listedbelow) engaged in the development of single-use bioreactors; each profile featuresan overview of the developer, details related to its product portfolio, andrecent developments, and an informed future outlook:
§ Celartia
§ Cell Culture Company
§ Cellexus
§ CerCell
§ CESCO Bioengineering
§ Cytiva
§ Eppendorf
§ Merck Millipore
§ Pall Corporation
§ PBS Biotech
§ PerfuseCell
§ Pierre Guerin
§ ProlifeCell
§ Sartorius StedimBiotech
§ Solaris Biotech
§ Synthecon
§ Thermo FisherScientific
For additional details, please visit
https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html
You may also be interested in the following titles:
1. 3D Cell Culture Marketby Scaffold Format Market, (3rd Edition), 2020-2030
2. Cell Line Developmentand Characterization Services Market, (2nd Edition), 2020-2030
3. Automatedand Closed Cell Therapy Processing Systems Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter- https://twitter.com/RootsAnalysis
